Forsythoside E Alleviates Liver Injury by Targeting PKM2 Tetramerization to Promote Macrophage M2 Polarization
Advanced Science · 2026-01 · 13 (6)
DOI: 10.1002/advs.202514514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.11.2025. Verfasst von Bingxin Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Ch…. Hauptthemen laut MEDLINE: Macrophages, Sepsis, Pyruvate Kinase, Thyroid Hormones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Guangdong Key Laboratory for translational Cancer research of Chinese Medicine.
Abstract (Originalsprache)
Sepsis‐induced liver injury is closely associated with poor prognosis in septic patients. In this study, through integrated approaches including high‐throughput virtual screening, target fishing technology, and atomic force microscopy (AFM) analysis, Forsythiaside E (FE) is first identified as a novel allosteric activator of pyruvate kinase M2 (PKM2) that promotes tetramer formation. Mutant protein construction combined with dynamic light scattering (DLS) and fluorescence resonance energy transfer (FRET) reveals FE binds to PKM2 K311 to promote tetramer formation. Employing Seahorse XF metabolic analyzers, real‐time single‐cell multi‐modal analysis systems, and transcriptome sequencing, it is revealed that FE‐mediated PKM2 tetramerization induces metabolic reprogramming in macrophages while suppressing STAT3 phosphorylation and subsequent NLRP3 transcriptional activation. In vivo assessments indicate that FE exhibited no significant multi‐organ toxicity. FE alleviates sepsis‐induced liver injury by promoting macrophage polarization toward the M2 anti‐inflammatory phenotype. Further validation through macrophage‐specific overexpression of PKM2 WT/K311A in mice confirms FE's mechanism of action. Collectively, this study elucidates the molecular mechanism by which FE alleviates sepsis‐associated liver injury through targeted PKM2 tetramerization and proposes an innovative metabolic‐epigenetic coordinated regulation strategy for sepsis‐related liver injury treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Traditional Chinese Medicine Syndrome, International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510006, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, SAR, China.
ORCID-Profile: Caiyan Wang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Guangdong Key Laboratory for translational Cancer research of Chinese Medicine
- Chinese Medicine Guangdong Laboratory
Zitieren
APA
Wu, B., Yu, X., Li, Y., An, L., Zhang, R., Zhang, R., Zhang, F., Liu, Z., & Wang, C. (2026). Forsythoside E Alleviates Liver Injury by Targeting PKM2 Tetramerization to Promote Macrophage M2 Polarization. Advanced Science, 13(6). https://doi.org/10.1002/advs.202514514
Vancouver
Wu B, Yu X, Li Y, An L, Zhang R, Zhang R, et al. Forsythoside E Alleviates Liver Injury by Targeting PKM2 Tetramerization to Promote Macrophage M2 Polarization. Advanced Science. 2026;13(6). doi:10.1002/advs.202514514
BibTeX
@article{Wu2026,
author = {Wu, Bingxin and Yu, Xuechun and Li, Yanling and An, Lin and Zhang, Rongrong and Zhang, Rong and Zhang, Fan and Liu, Zhongqiu and Wang, Caiyan},
title = {Forsythoside E Alleviates Liver Injury by Targeting PKM2 Tetramerization to Promote Macrophage M2 Polarization},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {6},
doi = {10.1002/advs.202514514}
}
EUVIMED